West Virginia · 2026 Regular Session · Bill

HB 4626: Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine

Vetoed Last action April 2, 2026: Vetoed by Governor 4/1/2026

Plain-language summary

HB 4626 is a bill introduced in the West Virginia House on January 21, 2026. According to its official title, it concerns: Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine. Primary sponsor: Ryan Browning (Republican). It lists 6 additional sponsors. Most recent recorded action (April 2, 2026): Vetoed by Governor 4/1/2026.

Sponsors

Primary sponsor: Ryan Browning (Republican). 6 co-sponsors.